Blood Pressure and Cardiovascular Diseases in Chinese Men and Women with Type 2 Diabetes: A Prospective Cohort Study
Fiona Bragg,Jim Halsey,Yu Guo,Hua Zhang,Ling Yang,Xiaohui Sun,Pei Pei,Yiping Chen,Huaidong Du,Canqing Yu,Robert Clarke,Jun Lv,Junshi Chen,Liming Li,Zhengming Chen
DOI: https://doi.org/10.2139/ssrn.3707443
2020-01-01
Abstract:Background: Controversy persists about the associations of blood pressure with cardiovascular diseases (CVD) in diabetes and the associated disease burden, particularly in low- and middle-income country populations. We aimed to assess these associations among Chinese adults with type 2 diabetes (T2D).
Methods: In 2004-08, the China Kadoorie Biobank recruited 512,715 adults aged 30–79 years from 10 localities across China, including 26,315 with T2D but no prior CVD, followed-up for ~9 years. Cox regression yielded adjusted HR for major CVD and all-cause mortality associated with usual (longer-term average) blood pressure. Attributable fractions were estimated to assess cardiovascular mortality burden due to uncontrolled hypertension (SBP ≥130 mmHg or DBP ≥80 mmHg).
Findings: Overall, 75.7% of participants had self-reported (24.8%) or screen-detected (50.9%) hypertension. Among individuals with self-reported hypertension, 82.3% were treated, of whom 9.3% achieved control. There were positive log-linear associations of blood pressure with CVD, with no evidence of a threshold down to ~120 mmHg for usual SBP. Each 10 mmHg higher usual SBP was associated with HR of 1.28 (95% CI 1.25-1.30), 1.18 (1.15-1.21), 1.17 (1.15-1.19) and 1.45 (1.38-1.52) for cardiovascular death (n=1,807), major coronary event (n=1,190), ischaemic stroke (n=4,362) and intracerebral haemorrhage (n=469), respectively. There was an apparent J-shaped association with all-cause mortality (n=4,503). In this population, uncontrolled hypertension accounted for 39% of cardiovascular deaths.
Interpretation: Uncontrolled hypertension is common in Chinese adults with T2D, resulting in substantial excess risks of CVD. Improved hypertension management in T2D could avoid a large number of cardiovascular-related deaths in China.
Funding Statement: The baseline survey and the first re-survey were supported by a research grant from the Kadoorie Charitable Foundation in Hong Kong. The long-term continuation of the project is supported by program grants from the UK Wellcome Trust (088158/Z/09/Z, 104085/Z/14/Z), the Chinese Ministry of Science and Technology (2011BAI09B01, 2012-14), the Chinese National Natural Science Foundation (81390540 / 81390541 / 81390544, 2014-18) and the National Key Research and Development Program of China (2016YFC0900500 / 2016YFC0900501 / 2016YFC0900504 / 2016YFC1303904, 2016-2021). The British Heart Foundation, Medical Research Council and Cancer Research UK provide core funding to the Oxford CTSU. Fiona Bragg acknowledges support from the BHF Centre of Research Excellence, Oxford (RE/13/1/30181).
Declaration of Interests: We declare that we have no conflict of interest.
Ethics Approval Statement: Ethics approval was obtained from relevant local, national and international ethics committees prior to commencement of the study. All participants provided informed written consent.